A Study of Liposome-entrapped Mitoxantrone Hydrochloride Injection in Relapsed/Refractory Peripheral T-cell Lymphoma and NK/T-cell Lymphoma

Clinical trial NCT03776279 · UNKNOWN

Trial details

NCT number: NCT03776279
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed or Refractory Peripheral T-cell and NK/T-cell Lymphoma

Start date: 2018-04-02
Primary completion: 2020-12-30
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.